R Schvarcz
Overview
Explore the profile of R Schvarcz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weiland O, HOLLANDER A, Mattsson L, Glaumann H, Lindahl K, Schvarcz R, et al.
J Viral Hepat
. 2008 May;
15(9):641-5.
PMID: 18507753
Mono-therapy with pegylated interferon (peg-IFN) has shown that a lower-than-standard dose yields the same sustained viral response (SVR) rates as standard doses for chronic hepatitis C virus (HCV) infection caused...
2.
Bruchfeld A, Lindahl K, Reichard O, Carlsson T, Schvarcz R
J Viral Hepat
. 2006 Apr;
13(5):316-21.
PMID: 16637862
Standard therapy for chronic hepatitis C (HCV) is pegylated interferon in combination with ribavirin. There is limited experience with either drug in dialysis [end stage renal disease (ESRD)]. Six haemodialysis...
3.
Bruchfeld A, Lindahl K, Reichard O, Carlsson T, Schvarcz R
Nephrol Dial Transplant
. 2006 Mar;
21(5):1444-5.
PMID: 16517569
No abstract available.
4.
Bruchfeld A, Lindahl K, Stahle L, Schvarcz R
J Hepatol
. 2005 Dec;
44(2):432-3.
PMID: 16338023
No abstract available.
5.
Lindahl K, Schvarcz R, Bruchfeld A, Stahle L
J Viral Hepat
. 2004 Jan;
11(1):84-7.
PMID: 14738562
Ribavirin in combination with interferon alpha-2 or pegylated interferon is the standard treatment for chronic hepatitis C. The current dosage recommendations for ribavirin are based on body weight (bw). Ribavirin...
6.
Bruchfeld A, Stahle L, Andersson J, Schvarcz R
Nephrol Dial Transplant
. 2001 Jul;
16(8):1729.
PMID: 11477195
No abstract available.
7.
Bruchfeld A, Stahle L, Andersson J, Schvarcz R
J Viral Hepat
. 2001 Jul;
8(4):287-92.
PMID: 11454181
Standard treatment for chronic hepatitis C is with interferon (IFN)-alpha and ribavirin for 6-12 months. In dialysis patients only interferon therapy is currently used due to the lack of knowledge...
8.
Carlsson T, Lindahl K, Schvarcz R, Wejstal R, Uhnoo I, Shev S, et al.
J Viral Hepat
. 2000 Dec;
7(6):409-13.
PMID: 11115051
Interferon (IFN) alpha in combination with ribavirin (RIB) is standard therapy for patients with chronic hepatitis C virus (HCV) infection. However, many patients do not respond with sustained HCV clearance...
9.
Schvarcz R, Rudbeck G, Soderdahl G, Stahle L
Transplantation
. 2000 Jun;
69(10):2194-5.
PMID: 10852623
A 49-year old male patient with severe hemophilia A, coinfected with HIV and HCV, who underwent orthoptic liver transplantation because of hepatitis C cirrhosis is presented. We describe a strong...
10.
Svensson J, Bruchfeld A, Schvarcz R, Stahle L
Ther Drug Monit
. 2000 Apr;
22(2):215-8.
PMID: 10774636
A rapid assay for determination of ribavirin in serum using solid-phase extraction (SPE), high-performance liquid chromatography (HPLC), and UV-detection was developed. The SPE uses phenylboronic acid columns with an approximately...